Moderna's late-stage trial for its COVID-flu combination vaccine yielded positive results, the pharmaceutical and biotechnology company announced Monday. The combination vaccine, which Moderna calls mRNA-1083, produced a higher immune response than standalone vaccines for COVID-19 or influenza. The results were also seen among trail participants 65 years and older, whom often don't show as strong a response to vaccines as younger individuals. The announcement makes Moderna the first to report positive Phase 3 data for its combination vaccine, giving the company a slight edge over Pfizer and BioNTech, which began a Phase 3 trial for its combined flu and COVID-19 vaccine last year.
Hence then, the article about moderna sees positive results in covid flu vaccine trial was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Moderna sees positive results in COVID-flu vaccine trial )